Announcements
Drinks
![Scope converts German Merck’s ratings into unsolicited subscription ratings available on ScopeOne](https://www.scopegroup.com/ScopeOneApi/images/announcement-img?imageName=mitteilung_ab51344fbb288fd2351de38c5b9c0f6bad22b7f17712c633831499a68df4037e.jpg)
29/12/2023 Monitoring note EN
Scope converts German Merck’s ratings into unsolicited subscription ratings available on ScopeOne
Following Merck’s request for a withdrawal of Scope’s public ratings on the German conglomerate, the rating agency has converted all ratings into unsolicited subscription ratings.
![Scope has completed a monitoring review for Merck KGaA](https://www.scopegroup.com/ScopeOneApi/images/announcement-img?imageName=mitteilung_77e87177a2ec6c4615fea65ec3b6707b5371ecdeb26f0b8711f91b740db58905.jpg)
19/8/2022 Monitoring note EN
Scope has completed a monitoring review for Merck KGaA
No action has been taken on the ratings until Scope received additional guidance on the company's medium-term cash deployment and deleveraging policy. This will likely be provided within the upcoming capital markets day.
![Merck's intended takeover of Versum likely to be credit-neutral despite increased leverage](https://www.scopegroup.com/ScopeOneApi/images/announcement-img?imageName=mitteilung_e569049e8746110e53e45c0b9ab839196f1ba87d7c5acade641d0a7c7c14b871.jpg)
1/3/2019 Monitoring note EN
Merck's intended takeover of Versum likely to be credit-neutral despite increased leverage
Expected deterioration in credit metrics likely to be mitigated by divestiture proceeds and rapid pay-back of debt within 24 months following the takeover; neutral to slightly positive effects anticipated for the business risk profile.